Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.

Gonzague JourdainNicole Ngo-Giang-HuongTim R CresseyLei HuaLinda HarrisonCamlin TierneyNicolas SalvadoriLuc DeckerPatrinee TraisathitWasna SirirungsiWoottichai KhamduangChureeratana BowonwatanuwongThanyawee PuthanakitGeorge K SiberryDiane Heather WattsTrudy V MurphyJullapong AchalapongSuchat HongsiriwonVirat KlinbuayaemSatawat ThongsawatRaymond T ChungStanislas PolNantasak Chotivanich

Published in: BMC infectious diseases (2016)

ClinicalTrials.gov Identifier NCT01745822 .

Keyphrases

hepatitis b virus
phase iii
double blind
placebo controlled
clinical trial
phase ii
liver failure
phase ii study
study protocol
mental health
open label
antiretroviral therapy
randomized controlled trial
radiation therapy
squamous cell carcinoma
rectal cancer